コンテンツへスキップ
Merck
すべての画像(1)

Key Documents

安全性情報

SRP6316

Sigma-Aldrich

アンチトロンビン III ヒト血漿由来

≥95% (SDS-PAGE)

別名:

SERPINC1

ログイン組織・契約価格を表示する


About This Item

UNSPSCコード:
12352202
NACRES:
NA.32

由来生物

human

アッセイ

≥95% (SDS-PAGE)

形状

lyophilized

分子量

58 kDa

包装

pkg of 100 μg
pkg of 500 μg

UniProtアクセッション番号

輸送温度

wet ice

保管温度

−20°C

遺伝子情報

human ... SERPINC1(462)

詳細

SerpinC1, also known as antithrombin III (AT III), is a member of the serpin superfamily of serine protease inhibitors. The gene is mapped to human chromosome 1. SerpinC1 is a glycoprotein with three β-sheets and nine α-helices. The protein has an active site region and a heparin binding site.

生物化学的/生理学的作用

SerpinC1, also known as antithrombin III (AT III), has been found to be a marker for disseminated intravascular coagulation (DIC) and to be of prognostic significance in septic patients. Antithrombin III synthesized in the liver is the principal plasma serpin of blood coagulation proteases and inhibits thrombin and other factors such as Xa by the formation of covalently linked complexes. Thus, it is one of the most important coagulation inhibitors and the fundamental enzyme for the therapeutical action of heparin. The inhibitory activity of AT III undergoes a dramatic increase in the presence of heparin and other glycosaminoglycans. Antithrombin III mediates the promotion of prostaglandin release, an inhibitor of leucocyte activation and downregulation of many proinflammatory cytokines. It exerts anti-inflammatory properties in addition to its anti-coagulative mechanisms. The deficiency or functional abnormality of AT III may result in an increased risk of thromboembolic disease, such as deep vein thrombosis and pulmonary embolism. In addition, it has been reported that AT III can alter or influence inflammatory processes via inhibition of NF (nuclear factor)-κB activation or actin polymerization. It is found in normal serum at 15mg/100mL. Found at higher levels in plasma than in serum because of complexing with thrombin during coagulation. Clinically, reduced levels are indicative of hypercoagulability. Reduction in the levels of antithrombin III enhances the severity of renal ischemia/reperfusion injury.

物理的形状

Lyophilized from 50 mM Tris-HCl, pH 8.0, with 150 mM NaCl.

再構成

In water or aqueous buffer

保管分類コード

13 - Non Combustible Solids

WGK

nwg


適用法令

試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。

Jan Code

SRP6316-500UG:
SRP6316-100UG:


試験成績書(COA)

製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。

以前この製品を購入いただいたことがある場合

文書ライブラリで、最近購入した製品の文書を検索できます。

文書ライブラリにアクセスする

Plasma antithrombin III and thrombin generation time: correlation with hemoglobin A1 and fasting serum glucose in young diabetic women.
Sowers JR, et al.
Diabetes Care, 3, 655-658 (1980)
Laboratory tests for antithrombin deficiency.
Khor B and Van Cott EM
American Journal of Hematology, 85, 947-950 (2010)
Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction.
Inthorn D, et al.
Shock, 8, 328-334 (1997)
The anti-inflammatory properties of antithrombin III: new therapeutic implications.
Okajima K and Uchiba M
Seminars in Thrombosis and Hemostasis, 24, 27-32 (1998)
Antithrombin III inhibits nuclear factor kappaB activation in human monocytes and vascular endothelial cells.
Oelschlager C, et al.
Blood, 99, 4015-4020 (2002)

ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.

製品に関するお問い合わせはこちら(テクニカルサービス)